Location History:
- Lingenfeld, DE (2012 - 2014)
- Lingenfield, DE (2017)
Company Filing History:
1 out of 167 
1 out of 3,923 
1 out of 139 
Years Active: 2012-2017
Title: Innovator Spotlight: Norbert Steiger
Introduction
Norbert Steiger is a prominent inventor based in Lingenfeld, Germany, recognized for his significant contributions to the pharmaceutical industry. With a total of three patents to his name, Steiger's work exemplifies the innovative spirit in developing effective treatments for various disorders.
Latest Patents
Steiger's latest patents showcase advancements in pharmaceutical formulations. One of his notable inventions is a "Pharmaceutical dosage form for oral administration of a Bcl-2 family inhibitor." This patent describes a solid dispersion product that comprises an intricate mixture designed to treat proliferative disorders by employing a specific chemical compound in a pharmaceutically acceptable format.
His second relevant patent, "Melt-processed imatinib dosage form," pertains to an advanced dosage form containing imatinib. This formulation achieves high drug loading and boasts an efficient preparation process. Furthermore, it promises the release of the active ingredient in a pH-independent manner, thus enhancing its therapeutic effectiveness and providing extended-release options.
Career Highlights
Throughout his career, Norbert Steiger has worked with established companies such as AbbVie Deutschland GmbH & Co. KG and Novartis AG. His roles in these leading organizations have enabled him to drive innovation and focus on pharmaceutical development that meets the needs of patients.
Collaborations
Steiger has had the opportunity to collaborate with esteemed colleagues, including Martin Knobloch and Harald Hach. These partnerships have played a crucial role in refining his inventions, amplifying their potential impact in the market, and advancing pharmaceutical technologies.
Conclusion
Norbert Steiger's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to developing effective treatments. With a firm background in research and collaboration with prestigious companies and peers, he continues to influence the landscape of medication delivery systems, ultimately working towards better health solutions for patients worldwide.